Literature DB >> 8046330

Collagen-induced arthritis in T cell receptor V beta congenic B10.Q mice.

G H Nabozny1, M J Bull, J Hanson, M M Griffiths, H S Luthra, C S David.   

Abstract

B10.Q (H-2q) mice congenic for the truncated T cell receptor (TCR) V beta a and V beta c haplotypes were derived to examine the influence of TCR V beta genomic deletions in murine collagen-induced arthritis (CIA). Previous studies using gene complementation and segregation analyses suggested that in SWR (H-2q) mice, possession of the V beta a gene deletion results in CIA resistance. However, other studies have suggested alternative hypotheses. Thus, analysis of TCR V beta congenic mice allows for direct examination of V beta genotypes in CIA control. After immunization with bovine type II collagen, B10.Q-V beta a mice showed no difference in arthritis susceptibility, onset, or severity when compared with prototype B10.Q mice. In contrast, B10.Q-V beta c mice, which lack the V beta 6, 15, 17, and 19 families in addition to the V beta a deletion, were highly resistant to CIA. In vivo depletion of V beta 6+ T cells in B10.Q-V beta a mice significantly delayed arthritis onset suggesting that, among those V beta genes present in V beta a but absent in V beta c, V beta 6+ T cells contribute to arthritogenesis. Our findings show that, in B10.Q-V beta congenic mice, while the V beta a genotype does not prevent CIA, the highly truncated V beta c genotype renders B10.Q mice resistant to CIA. Thus, deletions within the V beta TCR genome can indeed influence CIA and suggests that the TCR repertoire displays only marginal flexibility in response to arthritogenic stimuli.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046330      PMCID: PMC2191611          DOI: 10.1084/jem.180.2.517

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  45 in total

1.  Characterization of a rat monoclonal antibody specific for a determinant encoded by the V beta 7 gene segment. Depletion of V beta 7+ T cells in mice with Mls-1a haplotype.

Authors:  C Y Okada; B Holzmann; C Guidos; E Palmer; I L Weissman
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

2.  Coding sequence polymorphisms among V beta T cell receptor genes.

Authors:  L R Smith; A Plaza; P A Singer; A N Theofilopoulos
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

3.  In vivo elimination of T cells expressing specific T-cell receptor V beta chains in mice susceptible to collagen-induced arthritis.

Authors:  T J Goldschmidt; L Jansson; R Holmdahl
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

4.  The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities.

Authors:  J T Hom; L D Butler; P E Riedl; A M Bendele
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

5.  In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice.

Authors:  J T Hom; A M Bendele; D G Carlson
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

6.  Influence of complement C5 and V beta T cell receptor mutations on susceptibility to collagen-induced arthritis in mice.

Authors:  S Banerjee; G D Anderson; H S Luthra; C S David
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

7.  Identification of T-cell receptor V beta deletion mutant mouse strain AU/ssJ (H-2q) which is resistant to collagen-induced arthritis.

Authors:  T M Haqqi; S Banerjee; W L Jones; G Anderson; M A Behlke; D Y Loh; H S Luthra; C S David
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

8.  The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells.

Authors:  J Bill; O Kanagawa; D L Woodland; E Palmer
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

9.  Positive selection determines T cell receptor V beta 14 gene usage by CD8+ T cells.

Authors:  N S Liao; J Maltzman; D H Raulet
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

10.  RIII S/J (H-2r). An inbred mouse strain with a massive deletion of T cell receptor V beta genes.

Authors:  T M Haqqi; S Banerjee; G D Anderson; C S David
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Role of superantigens in experimental arthritis.

Authors:  A Abdelnour; Y X Zhao; T Bremell; R Holmdahl; A Tarkowski
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.

Authors:  P Mukherjee; S-Y Yang; B Wu; Z Song; L K Myers; P D Robbins; P H Wooley
Journal:  Ann Rheum Dis       Date:  2005-04-28       Impact factor: 19.103

3.  HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.

Authors:  S D Khare; J Hansen; H S Luthra; C S David
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

4.  IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints.

Authors:  C-Q Chu; Z Song; L Mayton; B Wu; P H Wooley
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

5.  Self tolerance to T cell receptor V beta sequences.

Authors:  F Falcioni; D Vidović; E S Ward; D Bolin; G Singh; H Shah; B Ober; Z A Nagy
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

6.  Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis.

Authors:  M A Gonzalez-Gay; G H Nabozny; M J Bull; E Zanelli; J Douhan; M M Griffiths; L H Glimcher; H S Luthra; C S David
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

Review 7.  Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review.

Authors:  C Henrique Alves; Eric Farrell; Marijn Vis; Edgar M Colin; Erik Lubberts
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.